Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Zech
How Dry Was the Younger Dryas? Evidence From a Coupled ≪i>δ</I><sup>2</Sup>H–<i>δ</I><sup>18</Sup>O Biomarker Paleohygrometer Applied to the Gemündener Maar Sediments, Western Eifel, Germany
Climate of the Past
Planetary Change
Global
Stratigraphy
Paleontology
Evaluation of Bacterial Glycerol Dialkyl Glycerol Tetraether and ≪sup>2</Sup>H&#8211;<sup>18</Sup>O Biomarker Proxies Along a Central European Topsoil Transect
Biogeosciences
Earth-Surface Processes
Ecology
Systematics
Evolution
Behavior
Reconstructing Quaternary Vegetation History in the Carp-Athian Basin, SE Europe, Using N-Alkane Biomarkers as Mole-Cular Fossils: Problems and Possible Solutions, Potential and Limitations
Quaternary International
Earth-Surface Processes
Ataxia Telangiectasia Gene Mutation in Isolated Segmental Dystonia Without Ataxia and Telangiectasia
Movement Disorders Clinical Practice
Neurology
Chemotaxonomic Patterns of Vegetation and Soils Along Altitudinal Transects of the Bale Mountains, Ethiopia, and Implications for Paleovegetation Reconstructions – Part II: Lignin-Derived Phenols and Leaf-Wax-Derived ≪i>n</I>-Alkanes
E&G Quaternary Science Journal
Related publications
Neuropsychiatric Outcomes After Stroke – Authors' Reply
The Lancet Neurology
Neurology
Maximising the Value of Research for Brain Health
The Lancet Neurology
Neurology
Cannabidiol in Patients With Treatment-Resistant Epilepsy
The Lancet Neurology
Neurology
WHO Takes Up the Baton on Dementia
The Lancet Neurology
Neurology
Learning About the Brain With Comics
The Lancet Neurology
Neurology
Functional (Psychogenic) Saccadic Oscillations and Oculogyric Crises – Authors' Reply
The Lancet Neurology
Neurology
Dream Weaver
The Lancet Neurology
Neurology
The Evolution of Universally Accessible Building Design
The Lancet Neurology
Neurology
Global, Regional, and National Burden of Meningitis, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016
The Lancet Neurology
Neurology
Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial
The Lancet Neurology
Neurology
